Works matching IS 10837159 AND DT 2021 AND VI 26 AND IP 2

Results: 32

A Medical Pearl Harbor: Pandemic Uncovers Societal Fissures and Leadership Breaches.
Published in:
Oncologist, 2021, v. 26, n. 2, p. 89, doi. 10.1002/onco.13677
By:
- Chabner, Bruce A.;
- Bates, Susan E.;
- Fojo, Antonio Tito;
- Murphy, Ann;
- Sartor, A. Oliver;
- Murphy, Martin J.
Publication type:
Article
In Reply.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e350, doi. 10.1002/onco.13651
By:
- Nappi, Lucia;
- Ottaviano, Margaret;
- Rescigno, Pasquale;
- Messina, Carlo;
- Palmieri, Giovannella
Publication type:
Article
Metastatic Mediastinal Germ‐Cell Tumor and Concurrent COVID‐19: When Chemotherapy Is Not Deferrable.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e347, doi. 10.1002/onco.13647
By:
- Pedrazzoli, Paolo;
- Rondonotti, David;
- Cattrini, Carlo;
- Secondino, Simona;
- Ravanini, Paolo;
- Piralla, Antonio;
- Sainaghi, Pier Paolo;
- Brustia, Diego;
- Bozzola, Cristina;
- Gariglio, Marisa;
- Cossandi, Christian;
- Rosti, Giovanni;
- Gennari, Alessandra
Publication type:
Article
Edmonton Symptom Assessment Scale Time Duration of Self‐Completion Versus Assisted Completion in Patients with Advanced Cancer: A Randomized Comparison.
Published in:
Oncologist, 2021, v. 26, n. 2, p. 165, doi. 10.1002/onco.13619
By:
- Wong, Angelique;
- Tayjasanant, Supakarn;
- Rodriguez‐Nunez, Alfredo;
- Park, Minjeong;
- Liu, Diane;
- Zapata, Kresnier Perez;
- Allo, Julio;
- Frisbee‐Hume, Susan;
- Williams, Janet;
- Bruera, Eduardo
Publication type:
Article
Efficacy of FOLFOX in Patients with Aggressive Pancreatic Neuroendocrine Tumors After Prior Capecitabine/Temozolomide.
Published in:
Oncologist, 2021, v. 26, n. 2, p. 115, doi. 10.1002/onco.13611
By:
- Al‐Toubah, Taymeyah;
- Morse, Brian;
- Pelle, Eleonora;
- Strosberg, Jonathan
Publication type:
Article
Challenges and Opportunities in the Management of Diffuse Large B‐Cell Lymphoma in Older Patients.
Published in:
Oncologist, 2021, v. 26, n. 2, p. 120, doi. 10.1002/onco.13610
By:
- Di, Mengyang;
- Huntington, Scott F;
- Olszewski, Adam J.
Publication type:
Article
Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor‐Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy.
Published in:
Oncologist, 2021, v. 26, n. 2, p. 101, doi. 10.1002/onco.13609
By:
- Cook, Madeline M.;
- Al Rabadi, Luai;
- Kaempf, Andy J.;
- Saraceni, Megan M.;
- Savin, Michael A.;
- Mitri, Zahi I.
Publication type:
Article
Cancer in Lockdown: Impact of the COVID‐19 Pandemic on Patients with Cancer.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e342, doi. 10.1002/onco.13604
By:
- Moraliyage, Harsha;
- De Silva, Daswin;
- Ranasinghe, Weranja;
- Adikari, Achini;
- Alahakoon, Damminda;
- Prasad, Raj;
- Lawrentschuk, Nathan;
- Bolton, Damien
Publication type:
Article
Standardized Supportive Care Documentation Improves Safety of High‐Dose Methotrexate Treatment.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e327, doi. 10.1002/onco.13603
By:
- Alsdorf, Winfried H.;
- Karagiannis, Panagiotis;
- Langebrake, Claudia;
- Bokemeyer, Carsten;
- Frenzel, Christian
Publication type:
Article
Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair‐Deficient Prostate Cancer.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e270, doi. 10.1002/onco.13601
By:
- Sena, Laura A.;
- Fountain, Julia;
- Isaacsson Velho, Pedro;
- Lim, Su Jin;
- Wang, Hao;
- Nizialek, Emily;
- Rathi, Nityam;
- Nussenzveig, Roberto;
- Maughan, Benjamin L.;
- Velez, Miguel Gonzalez;
- Ashkar, Ryan;
- Larson, Amanda C.;
- Pritchard, Colin C.;
- Adra, Nabil;
- Bryce, Alan H.;
- Agarwal, Neeraj;
- Pardoll, Drew M.;
- Eshleman, James R.;
- Lotan, Tamara L.;
- Antonarakis, Emmanuel S.
Publication type:
Article
Patient Navigation to Improve Early Access to Supportive Care for Patients with Advanced Cancer in Resource‐Limited Settings: A Randomized Controlled Trial.
Published in:
Oncologist, 2021, v. 26, n. 2, p. 157, doi. 10.1002/onco.13599
By:
- Soto‐Perez‐de‐Celis, Enrique;
- Chavarri‐Guerra, Yanin;
- Ramos‐Lopez, Wendy Alicia;
- Alcalde‐Castro, Jacqueline;
- Covarrubias‐Gomez, Alfredo;
- Navarro‐Lara, África;
- Quiroz‐Friedman, Paulina;
- Sánchez‐Román, Sofía;
- Alcocer‐Castillejos, Natasha;
- Aguilar‐Velazco, José Carlos;
- Bukowski, Alexandra;
- Chávarri‐Maldonado, Juan Alberto;
- Contreras‐Garduño, Sergio;
- Krush, Lindsay;
- Inoyo, Itoro;
- Medina‐Campos, Andrea;
- Moreno‐García, María Luisa;
- Perez‐Montessoro, Viridiana;
- Bourlon, María T.;
- Peña‐Lopez, Roberto
Publication type:
Article
More Insights on the Use of γ‐Secretase Inhibitors in Cancer Treatment.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e298, doi. 10.1002/onco.13595
By:
- López‐Nieva, Pilar;
- González‐Sánchez, Laura;
- Cobos‐Fernández, María Ángeles;
- Córdoba, Raúl;
- Santos, Javier;
- Fernández‐Piqueras, José
Publication type:
Article
Extended RAS Analysis of the Phase III EPIC Trial: Irinotecan + Cetuximab Versus Irinotecan as Second‐Line Treatment for Patients with Metastatic Colorectal Cancer.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e261, doi. 10.1002/onco.13591
By:
- Sobrero, Alberto;
- Lenz, Heinz‐Josef;
- Eng, Cathy;
- Scheithauer, Werner;
- Middleton, Gary;
- Chen, Wenfeng;
- Esser, Regina;
- Nippgen, Johannes;
- Burris, Howard
Publication type:
Article
Navigating Diagnostic and Treatment Decisions in Non‐Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e306, doi. 10.1002/onco.13586
By:
- Popat, Sanjay;
- Navani, Neal;
- Kerr, Keith M.;
- Smit, Egbert F.;
- Batchelor, Timothy J.P.;
- Van Schil, Paul;
- Senan, Suresh;
- McDonald, Fiona
Publication type:
Article
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA‐Mutated Metastatic Castrate‐Resistant Prostate Cancer.
Published in:
Oncologist, 2021, v. 26, n. 2, p. 139, doi. 10.1002/onco.13585
By:
- Anscher, Mitchell S.;
- Chang, Elaine;
- Gao, Xin;
- Gong, Yutao;
- Weinstock, Chana;
- Bloomquist, Erik;
- Adeniyi, Oluseyi;
- Charlab, Rosane;
- Zimmerman, Sarah;
- Serlemitsos‐Day, Maritsa;
- Ning, Yang Min;
- Mayrosh, Ruth;
- Fuller, Barbara;
- Trentacosti, Ann Marie;
- Gallagher, Pamela;
- Bijwaard, Karen;
- Philip, Reena;
- Ghosh, Soma;
- Fahnbulleh, Frances;
- Diggs, Felicia
Publication type:
Article
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor‐Positive Metastatic Triple‐Negative Breast Cancer.
Published in:
Oncologist, 2021, v. 26, n. 2, p. 99, doi. 10.1002/onco.13583
By:
- Yuan, Yuan;
- Lee, Jin Sun;
- Yost, Susan E.;
- Frankel, Paul H.;
- Ruel, Christopher;
- Egelston, Colt A.;
- Guo, Weihua;
- Gillece, John D.;
- Folkerts, Megan;
- Reining, Lauren;
- Highlander, Sarah K.;
- Robinson, Kim;
- Padam, Simran;
- Martinez, Norma;
- Tang, Aileen;
- Schmolze, Daniel;
- Waisman, James;
- Sedrak, Mina;
- Lee, Peter P.;
- Mortimer, Joanne
Publication type:
Article
Breast Cancer‐Specific Mortality in Small‐Sized Tumor with Stage IV Breast Cancer: A Population‐Based Study.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e241, doi. 10.1002/onco.13567
By:
- Zheng, Yi‐Zi;
- Wang, Xian‐Ming;
- Fan, Lei;
- Shao, Zhi‐Ming
Publication type:
Article
A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2‐Negative Breast Cancer.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e230, doi. 10.1002/onco.13581
By:
- Lim, Bora;
- Song, Juhee;
- Ibrahim, Nuhad K.;
- Koenig, Kimberly B.;
- Chavez‐MacGregor, Mariana;
- Ensor, Joe E.;
- Gomez, Jill Schwartz;
- Krishnamurthy, Savitri;
- Caudle, Abigail S.;
- Shaitelman, Simona F.;
- Whitman, Gary J.;
- Valero, Vicente
Publication type:
Article
Dramatic Changes in Oncology Care Pathways During the COVID‐19 Pandemic: The French ONCOCARE‐COV Study.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e338, doi. 10.1002/onco.13578
By:
- Brugel, Mathias;
- Carlier, Claire;
- Essner, Christine;
- Debreuve‐Theresette, Adeline;
- Beck, Marie‐Françoise;
- Merrouche, Yacine;
- Bouché, Olivier
Publication type:
Article
A Phase I Open‐Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26–104/RFASE in Patients with Advanced Solid Malignancies.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e218, doi. 10.1002/onco.13576
By:
- Goedegebuure, Ruben S.A.;
- Wentink, Madelon Q.;
- Vliet, Hans J.;
- Timmerman, Peter;
- Griffioen, Arjan W.;
- Gruijl, Tanja D.;
- Verheul, Henk M.W.
Publication type:
Article
The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e279, doi. 10.1002/onco.13573
By:
- Wilson, Harper L.;
- D'Agostino, Ralph B.;
- Meegalla, Nuwan;
- Petro, Robin;
- Commander, Sara;
- Topaloglu, Umit;
- Zhang, Wei;
- Porosnicu, Mercedes
Publication type:
Article
Erdheim‐Chester Disease and Langerhans Cell Histiocytosis: A Case of Overlap Syndrome.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e345, doi. 10.1002/onco.13579
By:
- Ippolito, Davide;
- Ragusi, Maria;
- Maino, Cesare;
- Pecorelli, Anna;
- Giandola, Teresa;
- Franzesi, Cammillo Talei;
- Sironi, Sandro
Publication type:
Article
To Transplant or Not to Transplant During the SARS‐CoV‐2 Pandemic? That Is the Question.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e336, doi. 10.1002/onco.13563
By:
- Marino, Dario;
- Finotto, Silvia;
- Basso, Umberto;
- Galiano, Antonella;
- Bolshinsky, Maital;
- Amato, Ottavia;
- Marson, Piero;
- Tison, Tiziana;
- Colpo, Anna;
- Zagonel, Vittorina
Publication type:
Article
Prognostic Clinical and Radiographic Biomarkers for BRAF‐Targeted Therapy in Advanced Melanoma.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e333, doi. 10.1002/onco.13562
By:
- Shah, Kaustav P.;
- Song, Haocan;
- Ye, Fei;
- Johnson, Douglas B.
Publication type:
Article
Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e316, doi. 10.1002/onco.13552
By:
- Lacouture, Mario E.;
- Sibaud, Vincent;
- Anadkat, Milan J.;
- Kaffenberger, Benjamin;
- Leventhal, Jonathan;
- Guindon, Kathleen;
- Abou‐Alfa, Ghassan
Publication type:
Article
Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine‐Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX‐BC Study).
Published in:
Oncologist, 2021, v. 26, n. 2, p. 97, doi. 10.1002/onco.13547
By:
- Okano, Naohiro;
- Furuse, Junji;
- Ueno, Makoto;
- Morizane, Chigusa;
- Yamanaka, Takeharu;
- Ojima, Hidenori;
- Ozaka, Masato;
- Sasaki, Mitsuhito;
- Takahara, Naminatsu;
- Nakai, Yousuke;
- Kobayashi, Satoshi;
- Morimoto, Manabu;
- Hosoi, Hiroko;
- Maeno, Satoko;
- Nagashima, Fumio;
- Ikeda, Masafumi;
- Okusaka, Takuji
Publication type:
Article
A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell Carcinoma.
Published in:
Oncologist, 2021, v. 26, n. 2, p. 133, doi. 10.1002/onco.13539
By:
- Tsung, Irene;
- Worden, Francis P.;
- Fontana, Robert J.
Publication type:
Article
Sex Representation in Clinical Trials Associated with FDA Cancer Drug Approvals Differs Between Solid and Hematologic Malignancies.
Published in:
Oncologist, 2021, v. 26, n. 2, p. 107, doi. 10.1002/onco.13534
By:
- Mendis, Shehara;
- Anand, Seerat;
- Karasinska, Joanna M.;
- Dasari, Arvind;
- Unger, Joseph M.;
- Gothwal, Anirudh;
- Ellis, Lee M.;
- Varadhachary, Gauri;
- Kopetz, Scott;
- Overman, Michael J.;
- Raghav, Kanwal;
- Loree, Jonathan M.
Publication type:
Article
Serial Assessment of Depression and Anxiety by Patients and Providers in Women Receiving Chemotherapy for Early Breast Cancer.
Published in:
Oncologist, 2021, v. 26, n. 2, p. 147, doi. 10.1002/onco.13528
By:
- Nakamura, Zev M.;
- Deal, Allison M.;
- Nyrop, Kirsten A.;
- Chen, Yi Tang;
- Quillen, Laura J.;
- Brenizer, Tucker;
- Muss, Hyman B.
Publication type:
Article
Tumor Evolution in a Patient with Recurrent Endometrial Cancer and Synchronous Neuroendocrine Cancer and Response to Checkpoint Inhibitor Treatment.
Published in:
Oncologist, 2021, v. 26, n. 2, p. 90, doi. 10.1002/onco.13525
By:
- Trikalinos, Nikolaos A.;
- Chatterjee, Deyali;
- Winter, Kyle;
- Powell, Matthew;
- Yano, Motoyo
Publication type:
Article
Cost‐Effectiveness of Pembrolizumab plus Axitinib Versus Sunitinib as First‐Line Therapy in Advanced Renal Cell Carcinoma in the U.S.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e290, doi. 10.1002/ONCO.13522
By:
- Ding, Dong;
- Hu, Huabin;
- Shi, Yin;
- She, Longjiang;
- Yao, Linli;
- Zhu, Youwen;
- Zeng, Shan;
- Shen, Liangfang;
- Huang, Jin
Publication type:
Article
Changes in Stage Distribution and Disease‐Specific Survival in Differentiated Thyroid Cancer with Transition to American Joint Committee on Cancer 8th Edition: A Systematic Review and Meta‐Analysis.
Published in:
Oncologist, 2021, v. 26, n. 2, p. e251, doi. 10.1634/theoncologist.2020-0306
By:
- Lechner, Melissa G.;
- Bernardo, Angeli C.;
- Lampe, Alyssa;
- Praw, Stephanie Smooke;
- Tam, Samantha H.;
- Angell, Trevor E.
Publication type:
Article